Apimeds Pharmaceuticals CEO Erik Emerson Discusses Purified Bee Venom for Knee Osteoarthritis and Other Inflammatory Conditions

from WTR Healthcare Happenings · host Joe Brunetto

On this week’s WTR Biotech Spotlight, we speak with Apimeds CEO Erik Emerson about the newly NYSE listed company and the development of Apitox, a purified honeybee venom, for knee osteoarthritis and multiple sclerosis. We discuss the therapeutic properties of bee venom and the clinical/regulatory plans to bring Apitox to the US market. Listen to learn more about Apimeds and its novel approach to treat inflammatory pain.

Episode metadata supplied by the publisher feed · Published Jun 11, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Apimeds Pharmaceuticals CEO Erik Emerson Discusses Purified Bee Venom for Knee Osteoarthritis and Other Inflammatory Conditions

0:00 29:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of WTR Healthcare Happenings?

This episode is 29 minutes long.

When was this WTR Healthcare Happenings episode published?

This episode was published on June 11, 2025.

Can I download this WTR Healthcare Happenings episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!